David Seward is a Rare/Genetic physician affiliated with University of Vermont Medical Center. OpenAlex indexes 66 publications with 1,341 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingNIH funding
1 NIH research award on record, funded 2023–2024 per NIH RePORTER. The latest:
- STK11 loss of function and anti-PD-1 therapy resistance in KRAS-driven lung adenocarcinoma
University of Vermont & St Agric College
FY2024$173,208R21CA280266 - STK11 loss of function and anti-PD-1 therapy resistance in KRAS-driven lung adenocarcinoma
University of Vermont & St Agric College
FY2023$218,790R21CA280266
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Rup Tandan, MD
University of Vermont Medical Center
Seth Harlow, MD
University of Vermont Medical Center
Bruce Tranmer, MD
University of Vermont Medical Center
William Pendlebury, MD
University of Vermont Medical Center
Ronald Wapner, MD
Columbia University Irving Medical Center
Virginia Kimonis, MD
UC Irvine School of Medicine
Robert Hopkin, MD
Cincinnati Children's Hospital Medical Center
Joel Charrow, MD
Northwestern University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”